Vitalhub (TSE:VHI) Price Target Raised to C$12.50

Vitalhub (TSE:VHI) had its target price boosted by analysts at Canaccord Genuity Group from C$12.00 to C$12.50 in a report released on Thursday,BayStreet.CA reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s price target would suggest a potential upside of 14.05% from the stock’s previous close.

VHI has been the subject of a number of other reports. TD Securities raised Vitalhub to a “strong-buy” rating in a report on Monday, November 25th. Cormark increased their target price on Vitalhub from C$9.50 to C$10.50 and gave the stock a “buy” rating in a report on Wednesday, October 2nd. Four research analysts have rated the stock with a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average price target of C$10.05.

Vitalhub Stock Performance

TSE:VHI traded up C$0.06 during trading hours on Thursday, hitting C$10.96. The company’s stock had a trading volume of 34,895 shares, compared to its average volume of 134,637. The company has a market capitalization of C$557.32 million, a PE ratio of 99.64, a PEG ratio of 1.18 and a beta of 1.26. Vitalhub has a 52-week low of C$4.00 and a 52-week high of C$12.09. The business’s 50-day moving average is C$11.11 and its two-hundred day moving average is C$9.35.

Vitalhub Company Profile

Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.